Shandong Xinyi Pharmaceutical Co., Ltd.

Apply to life-threatening paroxysmal supraventricular tachycardia and ventricular fibrillation prevention, can also be used on other drugs ineffective paroxysmal supraventricular tachycardia, paroxysmal atrial flutter, atrial fibrillation, including merger WPW syndrome who sustained atrial fibrillation and atrial flutter maintenance therapy after electrical cardioversion. Can be used for continuous atrial fibrillation, atrial flutter when the control room rate. In addition there is a clear indication, in general, not suitable for the treatment of atrial, ventricular premature beats.